Bonaventura Clotet
AuthID: R-00F-DT9
11
TÃTULO: Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18 Full Text
AUTORES: Laila Darwich; Gemma Coma; Ruth Pena; Rocio Bellido; Ester J J Blanco; Jose A Este; Francesc E Borras; Bonaventura Clotet; Lidia Ruiz; Antoni Rosell; Felipe Andreo; Michael M E Parkhouse ; Margarita Bofill;
PUBLICAÇÃO: 2009, FONTE: IMMUNOLOGY, VOLUME: 126, NÚMERO: 3
AUTORES: Laila Darwich; Gemma Coma; Ruth Pena; Rocio Bellido; Ester J J Blanco; Jose A Este; Francesc E Borras; Bonaventura Clotet; Lidia Ruiz; Antoni Rosell; Felipe Andreo; Michael M E Parkhouse ; Margarita Bofill;
PUBLICAÇÃO: 2009, FONTE: IMMUNOLOGY, VOLUME: 126, NÚMERO: 3
12
TÃTULO: Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response
AUTORES: Koen Deforche; Alessandro Cozzi Lepri; Kristof Theys; Bonaventura Clotet; Ricardo J Camacho; Jesper Kjaer; Kristel Van Laethem; Andrew Phillips; Yves Moreau; Jens D Lundgren; Anne Mieke Vandamme ;
PUBLICAÇÃO: 2008, FONTE: ANTIVIRAL THERAPY, VOLUME: 13, NÚMERO: 3
AUTORES: Koen Deforche; Alessandro Cozzi Lepri; Kristof Theys; Bonaventura Clotet; Ricardo J Camacho; Jesper Kjaer; Kristel Van Laethem; Andrew Phillips; Yves Moreau; Jens D Lundgren; Anne Mieke Vandamme ;
PUBLICAÇÃO: 2008, FONTE: ANTIVIRAL THERAPY, VOLUME: 13, NÚMERO: 3
INDEXADO EM: 
Scopus 
WOS
Scopus WOS13
TÃTULO: Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: Recent data and consensus recommendations
AUTORES: Youle, M; Staszweski, S; Clotet, B; Arribas, JR; Blaxhult, A; Carosi, G; DeJesus, E; Di Perri, G; Estrada, V; Fisher, M; Kovacs, C; Kulasegaram, R; Lazzarin, A; Marriott, D; Munoz, L; Reynes, J; Shalit, P; Slim, J; Tsoukas, C; Vaccaro, A; ...Mais
PUBLICAÇÃO: 2006, FONTE: HIV CLINICAL TRIALS, VOLUME: 7, NÚMERO: 2
AUTORES: Youle, M; Staszweski, S; Clotet, B; Arribas, JR; Blaxhult, A; Carosi, G; DeJesus, E; Di Perri, G; Estrada, V; Fisher, M; Kovacs, C; Kulasegaram, R; Lazzarin, A; Marriott, D; Munoz, L; Reynes, J; Shalit, P; Slim, J; Tsoukas, C; Vaccaro, A; ...Mais
PUBLICAÇÃO: 2006, FONTE: HIV CLINICAL TRIALS, VOLUME: 7, NÚMERO: 2
14
TÃTULO: A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients
AUTORES: van Leeuwen, R; Katlama, C; Murphy, RL; Squires, K; Gatell, J; Horban, A; Clotet, B; Staszewski, S; van Eeden, A; Clumeck, N; Moroni, M; Pavia, AT; Schmidt, RE; Gonzalez Lahoz, J; Montaner, J; Antunes, F ; Gulick, R; Banhegyi, D; van der Valk, M; Reiss, P; ...Mais
PUBLICAÇÃO: 2003, FONTE: AIDS, VOLUME: 17, NÚMERO: 7
AUTORES: van Leeuwen, R; Katlama, C; Murphy, RL; Squires, K; Gatell, J; Horban, A; Clotet, B; Staszewski, S; van Eeden, A; Clumeck, N; Moroni, M; Pavia, AT; Schmidt, RE; Gonzalez Lahoz, J; Montaner, J; Antunes, F ; Gulick, R; Banhegyi, D; van der Valk, M; Reiss, P; ...Mais
PUBLICAÇÃO: 2003, FONTE: AIDS, VOLUME: 17, NÚMERO: 7
INDEXADO EM: WOS
WOS15
TÃTULO: Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
AUTORES: Miller, V; Vandamme, AM ; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait Khaled, M; Boucher, C; Brun Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; ...Mais
PUBLICAÇÃO: 2001, FONTE: AIDS, VOLUME: 15, NÚMERO: 3
AUTORES: Miller, V; Vandamme, AM ; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait Khaled, M; Boucher, C; Brun Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; ...Mais
PUBLICAÇÃO: 2001, FONTE: AIDS, VOLUME: 15, NÚMERO: 3
16
TÃTULO: Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up
AUTORES: Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V;
PUBLICAÇÃO: 2001, FONTE: ANTIVIRAL THERAPY, VOLUME: 6, NÚMERO: 1
AUTORES: Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V;
PUBLICAÇÃO: 2001, FONTE: ANTIVIRAL THERAPY, VOLUME: 6, NÚMERO: 1
INDEXADO EM: Scopus WOS
Scopus WOS17
TÃTULO: Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
AUTORES: Van Vaerenbergh, K; Van Laethem, K; Albert, J; Boucher, CAB; Clotet, B; Floridia, M; Gerstoft, J; Hejdeman, B; Nielsen, C; Pannecouque, C; Perrin, L; Pirillo, MF; Ruiz, L; Schmit, JC; Schneider, F; Schoolmeester, A; Schuurman, R; Stellbrink, HJ; Stuyver, L; Van Lunzen, J; ...Mais
PUBLICAÇÃO: 2000, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 44, NÚMERO: 8
AUTORES: Van Vaerenbergh, K; Van Laethem, K; Albert, J; Boucher, CAB; Clotet, B; Floridia, M; Gerstoft, J; Hejdeman, B; Nielsen, C; Pannecouque, C; Perrin, L; Pirillo, MF; Ruiz, L; Schmit, JC; Schneider, F; Schoolmeester, A; Schuurman, R; Stellbrink, HJ; Stuyver, L; Van Lunzen, J; ...Mais
PUBLICAÇÃO: 2000, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 44, NÚMERO: 8
18
TÃTULO: Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression
AUTORES: Gatell, JM; GonzalezLahoz, J; Clotet, B; Antunes, F ; Kasparova, L; GilAguado, A; Saballs, P; Santamaria, JM; Podzamczer, D; Miro, JM; Jou, A; Verdejo, J; Doroana, M; Thomis, J; Baquero, F; DeWit, S; Ledeine, JM; Gomez, JJG; Buira, E; Polo, R; ...Mais
PUBLICAÇÃO: 1996, FONTE: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, VOLUME: 12, NÚMERO: 3
AUTORES: Gatell, JM; GonzalezLahoz, J; Clotet, B; Antunes, F ; Kasparova, L; GilAguado, A; Saballs, P; Santamaria, JM; Podzamczer, D; Miro, JM; Jou, A; Verdejo, J; Doroana, M; Thomis, J; Baquero, F; DeWit, S; Ledeine, JM; Gomez, JJG; Buira, E; Polo, R; ...Mais
PUBLICAÇÃO: 1996, FONTE: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, VOLUME: 12, NÚMERO: 3
INDEXADO EM: Scopus WOS
Scopus WOS